These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10932156)

  • 1. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis.
    Zhang H; Cook J; Nickel J; Yu R; Stecker K; Myers K; Dean NM
    Nat Biotechnol; 2000 Aug; 18(8):862-7. PubMed ID: 10932156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
    Zhang H; Taylor J; Luther D; Johnston J; Murray S; Wyatt JR; Watt AT; Koo S; York-DeFalco C; Stecker K; Dean NM
    J Pharmacol Exp Ther; 2003 Oct; 307(1):24-33. PubMed ID: 12893848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice.
    Yu RZ; Zhang H; Geary RS; Graham M; Masarjian L; Lemonidis K; Crooke R; Dean NM; Levin AA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):388-95. PubMed ID: 11160622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference targeting Fas protects mice from fulminant hepatitis.
    Song E; Lee SK; Wang J; Ince N; Ouyang N; Min J; Chen J; Shankar P; Lieberman J
    Nat Med; 2003 Mar; 9(3):347-51. PubMed ID: 12579197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor blockade reduces Fas-induced hepatitis in mice.
    Jaume M; Jacquet S; Cavaillès P; Macé G; Stephan L; Blanpied C; Demur C; Brousset P; Dietrich G
    Hepatology; 2004 Nov; 40(5):1136-43. PubMed ID: 15389866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
    Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
    Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of liver tumor necrosis factor-alpha expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis.
    Dong L; Zuo L; Xia S; Gao S; Zhang C; Chen J; Zhang J
    J Gene Med; 2009 Mar; 11(3):229-39. PubMed ID: 19189285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase 8 small interfering RNA prevents acute liver failure in mice.
    Zender L; Hutker S; Liedtke C; Tillmann HL; Zender S; Mundt B; Waltemathe M; Gosling T; Flemming P; Malek NP; Trautwein C; Manns MP; Kuhnel F; Kubicka S
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7797-802. PubMed ID: 12810955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.
    Yu RZ; Lemonidis KM; Graham MJ; Matson JE; Crooke RM; Tribble DL; Wedel MK; Levin AA; Geary RS
    Biochem Pharmacol; 2009 Mar; 77(5):910-9. PubMed ID: 19056355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
    Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA
    Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury.
    Higuchi H; Miyoshi H; Bronk SF; Zhang H; Dean N; Gores GJ
    J Pharmacol Exp Ther; 2001 Dec; 299(3):866-73. PubMed ID: 11714870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand.
    Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G
    Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of non-signaling membrane-anchored death receptors protects murine livers in different models of hepatitis.
    Descamps D; Vigant F; Esselin S; Connault E; Opolon P; Perricaudet M; Benihoud K
    Hepatology; 2006 Aug; 44(2):399-409. PubMed ID: 16871589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.
    Boirivant M; Pallone F; Di Giacinto C; Fina D; Monteleone I; Marinaro M; Caruso R; Colantoni A; Palmieri G; Sanchez M; Strober W; MacDonald TT; Monteleone G
    Gastroenterology; 2006 Dec; 131(6):1786-98. PubMed ID: 17087939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
    Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
    Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure.
    Ryo K; Kamogawa Y; Ikeda I; Yamauchi K; Yonehara S; Nagata S; Hayashi N
    Am J Gastroenterol; 2000 Aug; 95(8):2047-55. PubMed ID: 10950056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.